Avalo Therapeutics

0 followers


Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.

Employees

11-50

Links

Org chart

Garry A. Neil
Chairman of the Board and Chief Executive Officer

Garry A. Neil

Collapse
Colleen Matkowski
SVP, Global Regulatory Affairs & Quality Assurance
Lisa Hegg
SVP, Program Management & Corporate Infrastructure & Clinical Operations
Dino C. Miano
SVP, CMC & Technical Operations
Paul Guptill
Vice President CMC Biologics
Mitchell Chan
Board Member